Researchers have successfully developed a novel drug to restore vision. The treatment method restores vision through retinal nerve regeneration.

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa ... high-dose and low-dose MCO-010 ...

Nanoscope Therapeutics has reported data from a mid-stage clinical trial that suggests its optogenetic therapy based on ... for incurable eye disease retinitis pigmentosa (RP).

a groundbreaking gene therapy targeting retinitis pigmentosa (RP). The data highlights sustained improvements in visual ...

Vision is one of the most crucial human senses, yet more than 300 million people worldwide are at risk of vision loss due to ...

The lack of this information has been a significant gap in research on eye diseases, especially those leading to irreversible ...

Significant advances have been made in the understanding of the genetics of retinitis pigmentosa (RP), a clinically ... Gene replacement therapy for several animal models of recessive disease ...

Retinitis pigmentosa (RP) is a group of genetic eye conditions that leads to incurable blindness. In the progression of symptoms for RP, night blindness generally precedes tunnel vision by years ...

"We look forward to further advancing this technology to help those with severe vision ... blind retinitis pigmentosa patients with ABCA4 variants received a single intravitreal gene therapy ...